|
Market Cap (18-May) $8,414,961,152 (204th) |
Close (30-Jun) $11.22 |
Volume (30-Jun) 664,557 |
Shortsold (5-May) 16,072,273 (4.76%) (53rd) |
|
52w High $31.97 |
52w Low $14.42 |
P/E 57.80 |
EPS 0.15 |
TLX released this announcement to the ASX on 19 August 2021, 8:07. The announcement is marked as price sensitive, and is 33 page(s) in length and 4.1MB in size.
You can view all announcements from TLX and see how they appear on a price chart on the announcements page.
At the date of this announcement, TLX was 0.688% short sold according to ASIC data. It was ranked the 230th most shorted stock on the ASX. It is now ranked as the 53rd most shorted stock on the ASX with 4.757% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from TLX | |
|---|---|
| Cleansing Notice | 28 June 2023, 8:23 |
| Application for quotation of securities - TLX | 28 June 2023, 8:23 |
| Proposed issue of securities - TLX | 21 June 2023, 18:12 |
| App 4D and Report for Half-Year Ended 30 June 2021 | 19 August 2021, 8:07 |
| GenesisCare Collaboration Expands Prostate Cancer Activity | 19 August 2021, 8:07 |
| Telix and Merck pan-cancer clinical collaboration | 18 August 2021, 9:26 |
| Two studies explore TLX assets in Breast Cancer Theranostics | 18 August 2021, 8:54 |
You must be logged in to post a reply.
Telix Pharmaceuticals 